Why the study?
Does recombinant human thrombomodulin improve the DIC resolution rate compared to unfractionated heparin in patients with DIC?
Does recombinant human thrombomodulin improve the DIC resolution rate compared to unfractionated heparin in patients with DIC?
Answers are grounded in this paper and cite their sources.
Recombinant human thrombomodulin, developed through successful industry-academia collaboration in Japan, is an effective and safe treatment for disseminated intravascular coagulation that demonstrates superiority over unfractionated heparin in resolving DIC.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Honda et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: